Abstract
Aims: Previously published diagnostic systems, based on ECG analysis and clinical parameters (Schwartz criteria and Keating criteria), have been used to estimate the probability of inherited long QT syndrome (LQTS). Nowadays, a certain diagnosis can often be made by DNA testing. We aimed to establish the predictive power of the Schwartz and Keating criteria, using DNA testing as a reference, and to determine the best diagnostic strategy. Methods and results: We studied 513 relatives (aged >10 years) of 77 consecutive LQTS probands with a known disease-causing mutation. The Schwartz criteria identified 'high probability of LQTS' (score ≥4) in 41 of 208 mutation carriers, yielding 19% sensitivity and 99% specificity. The Keating criteria had 36% sensitivity and 99% specificity. Alternatively, by analysing QTc duration alone, we found that 430 ms is the optimal cut-off value to distinguish carriers (≥430 ms) from non-carriers (
Original language | English |
---|---|
Pages (from-to) | 575-580 |
Number of pages | 6 |
Journal | European Heart Journal |
Volume | 28 |
Issue number | 5 |
DOIs | |
Publication status | Published - 1-Mar-2007 |
Keywords
- Diagnostic criteria
- Long QT syndrome
- Molecular genetics
- Ventricular arrhythmias
- DNA
- adult
- area under the curve
- article
- clinical trial
- controlled clinical trial
- controlled study
- diagnostic test
- diagnostic value
- DNA determination
- female
- gene mutation
- genetic screening
- genotype
- heterozygote
- human
- intermethod comparison
- long QT syndrome
- major clinical study
- male
- molecular genetics
- mutational analysis
- prediction
- priority journal
- probability
- QT interval
- relative
- scoring system
- sensitivity and specificity